Covered recipient · General Payments record
JENNIFER C BALA
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2019–2025
$2,735.75
- Reported across 36 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $391.63 | 8 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $150.00 | 1 |
| Retrophin, Inc. | $146.38 | 3 |
| CALLIDITAS THERAPEUTICS US INC. | $63.69 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $31.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Calliditas Therapeutics US Inc. | $29.31 | 08/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234991975 | CMS |
| Calliditas Therapeutics US Inc. | $18.99 | 10/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234991977 | CMS |
| Calliditas Therapeutics US Inc. | $15.39 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234991979 | CMS |
| Novartis Pharmaceuticals Corporation | $31.56 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200187679 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $150.00 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225320389 | CMS |
| Travere Therapeutics, Inc. | $10.11 | 05/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244407805 | CMS |
| Travere Therapeutics, Inc. | $125.00 | 07/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244407809 | CMS |
| Travere Therapeutics, Inc. | $11.27 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244407807 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.